Abstract

IntroductionThe Rheumatoid Arthritis Impact of Disease (RAID) is a patient-reported outcome measure evaluating the impact of rheumatoid arthritis (RA) on patient quality of life. It comprises 7 domains that are evaluated as continuous variables from 0 (best) to 10 (worst). The objective was to define and identify cut-off values for disease activity states as well as improvement scores in order to present results at the individual level (for example, patient in acceptable state, improved patient).MethodsPatients with definite active RA requiring anti-tumour necrosis factor (anti-TNF) therapy were seen at screening, baseline and after 4 and 12 weeks of etanercept therapy. Answers to "Gold standard" questions on improvement (MCII: Minimum Clinically Important Improvement) and an acceptable status (PASS: Patient Acceptable Symptom State) were collected as well as the RAID score and Disease Activity Score 28- erythrocyte sedimentation rate (DAS28-ESR). Cut-offs were defined by different techniques including empirical, measurement error and gold standard anchors. The external validity of these cut-offs was evaluated using the positive likelihood ratio (LR) based on the patient's perspective (for example, patient's global) and on low disease activity status (such as DAS28-ESR).ResultsNinety-seven (97) of the 108 recruited patients (age: 54 ± 13 years old, female gender: 75%, rheumatoid factor positive: 81%, disease duration: 8 ± 7 years, CRP: 18 ± 30 mg/l, DAS28-ESR: 5.4 ± 0.8) completed the 12 weeks of the study. The different techniques suggested thresholds ranging from 0.2 to 3 (absolute change) and from 6 to 50% (relative change) for defining MCII and thresholds from less than 1 to less than 4.2 for defining PASS. The evaluation of external validity (LR+) showed the highest LR+ was obtained with thresholds of 3 for absolute change; 50% for relative change and less than 2 for an acceptable status.ConclusionsThis study showed that thresholds defined for continuous variables are closely related to the methodological technique, justifying a systematic evaluation of their validity. Our results suggested that a change of at least 3 points (absolute) or 50% (relative) in the RAID score should be used to define a MCII and that a maximal value of 2 defines an acceptable status.Trial RegistrationClinicaltrial.gov: NCT004768053

Highlights

  • The Rheumatoid Arthritis Impact of Disease (RAID) is a patient-reported outcome measure evaluating the impact of rheumatoid arthritis (RA) on patient quality of life

  • Apart from patient-reported outcomes traditionally evaluated during the current standard assessment of RA, namely patient assessment of pain, functional disability and/or patient global assessment [4,5], other health domains are important for the patient such as fatigue, wellbeing and sleep pattern [6,7,8]

  • The disease had to be active according to the following definition: Disease Activity Score 28-erythrocyte sedimentation rate (DAS28-ESR) > 3.2 and at least one of the following: ≥ 4 swollen joints or C-reactive protein (CRP) ≥ 10 mg/l or ESR ≥ 28 mm/1st H, and the patient had to be eligible for tumornecrosis factor (TNF) blocker therapy as recommended by the French Society of Rheumatology [25]

Read more

Summary

Introduction

The Rheumatoid Arthritis Impact of Disease (RAID) is a patient-reported outcome measure evaluating the impact of rheumatoid arthritis (RA) on patient quality of life. It comprises 7 domains that are evaluated as continuous variables from 0 (best) to 10 (worst). Under the umbrella of the European League Against Rheumatism (EULAR), a patientreported composite index, the Rheumatoid Arthritis Impact of Disease (RAID) score has been proposed and validated [9,10,11,12] This composite index includes seven domains (pain, function, fatigue, physical and psychological wellbeing, sleep disturbance and coping). The RAID score is a continuous variable ranging from 0 (best) to 10 (worst) (Table 1)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.